CD4+ T cells containing replication-competent HIV proviruses that persist during ART and give rise to recrudescent viremia after ART cessation (operationally defined in this study as RCVR) represent the primary barrier to curing HIV infection. The gene discussed is CD4; the disease is HIV infectious disease.